DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Orteronel is an investigational drug.
There have been 17 clinical trials for Orteronel. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2012.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Breast Neoplasms, and Ovarian Neoplasms. The leading clinical trial sponsors are Millennium Pharmaceuticals, Inc., National Cancer Institute (NCI), and University of Wisconsin, Madison.
Recent Clinical Trials for Orteronel
|AR-inhibitor Bicalutamide in Treating Patients With TNBC||Jiangsu Province Hospital of Traditional Chinese Medicine||Phase 2|
|AR-inhibitor Bicalutamide in Treating Patients With TNBC||Nanning Second People's Hospital||Phase 2|
|AR-inhibitor Bicalutamide in Treating Patients With TNBC||The First People's Hospital of Lianyungang||Phase 2|